Research Funding Opportunities

To apprise the community of research areas that support that mission, NHGRI periodically publishes funding opportunities in the NIH Guide for Grants and Contracts. For your convenience, we have also listed the funding opportunities related to NHGRI on this webpage. NHGRI welcomes innovative investigator-initiated applications and encourages investigators with novel ideas to discuss potential applications with program staff during the concept development stage of the application. If you are considering applying for a Program Announcement with special review (PAR) , a Request for Applications (RFA), or an application that exceeds $500K in direct cost in any one year, we encourage you to review the Guidance to Potential Applicants for NHGRI Support.

For how NHGRI will treat new and non-competing applications, see the FY2020 Funding Policy.

• Investigator-Initiated Research on Genetic Counseling Processes and Practices (R01, Clinical Trial Optional)
  RFA-HG-20-048
  Application Receipt Date(s): October 28, 2020 and July 8, 2021
  Expiration Date: July 9, 2021
  
  Notice of Applicant Information Webinar and Frequently Asked Questions (FAQs) for Investigator-Initiated Research on Genetic Counseling Processes and Practices Request for Applications (RFAs): RFA-HG-20-048 and RFA-HG-20-049
  NOT-HG-20-057

• Investigator-Initiated Research on Genetic Counseling Processes and Practices (R21, Clinical Trial Optional)
  RFA-HG-20-049
  Application Receipt Date(s): October 28, 2020 and July 8, 2021
  Expiration Date: July 9, 2021
  
  Notice of Applicant Information Webinar and Frequently Asked Questions (FAQs) for Investigator-Initiated Research on Genetic Counseling Processes and Practices Request for Applications (RFAs): RFA-HG-20-048 and RFA-HG-20-049
  NOT-HG-20-057

• Center for Inherited Disease Research (CIDR) High Throughput Sequencing and Genotyping Resource Access (X01)
  PAR-20-230
  Application Due Date(s): Applications are accepted by continuous receipt.
  Expiration Date: July 9, 2023
   
• Systematic Characterization of Genomic Variation on Genomic Function and Phenotype (UM1 Clinical Trial Not Allowed)
  RFA-HG-20-043
  Application Receipt Date(s): November 4, 2020
  Expiration Date: November 5, 2020
   
• Defining Genomic Influence on Gene Network Regulation (U01 Clinical Trial Not Allowed)
  RFA-HG-20-044
  Application Receipt Date(s): November 4, 2020
  Expiration Date: November 5, 2020
   
• Single-cell Profiling of Regulatory Element and Gene Activity in Relationship to Genome Function (UM1 Clinical Trial Not Allowed)
  RFA-HG-20-045
  Application Receipt Date(s): November 4, 2020
  Expiration Date: November 5, 2020
  
  NOT-HG-20-055: Notice of Pre-Application Webinars for the Impact of Genomic Variation on Function (IGVF) Consortium FOAs (RFA-HG-20-043, RFA-HG-20-044, RFA-HG-20-045, RFA-HG-20-046, RFA-HG-20-047)
   
• Genomic Variation and Function Data and Administrative Coordinating Center (U24 Clinical Trial Not Allowed)
  RFA-HG-20-046
  Application Receipt Date(s): November 4, 2020
  Expiration Date: November 5, 2020
   
• Developing Predictive Models of the Impact of Genomic Variation on Function (U01 Clinical Trial Not Allowed)
  RFA-HG-20-047
  Application Receipt Date(s): November 4, 2020
  Expiration Date: November 5, 2020
  
   
• Ethical, Legal and Social Implications (ELSI) (Research R01 Clinical Trial Optional)
  PAR-20-254
  Application Due Dates: October 19 2020, February 17 2021, June 17 2021, October 19 2021, February 17 2022, June 17 2022, October 19 2022, February 17 2023, June 19 2023
  Expiration Date: July 20, 2023
   
• Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21) Clinical Trial Optional)
  PAR-20-255
  Application Due Dates: October 19, 2020, February 17, 2021, June 17, 2021, October 19, 2021, February 17, 2022, June 17, 2022, October 19, 2022, February 17, 2023, June 19, 2023
  Expiration Date: July 20, 2023
   
• Ethical, Legal and Social Implications (ELSI) Small Research Grant (R03) Clinical Trial Optional)
  PAR-20-257
  Application Due Dates: October 19 2020, February 17 2021, June 17 2021, October 19 2021, February 17 2022, June 17 2022, October 19 2022, February 17 2023, June 19 2023
  Expiration Date: July 20, 2023
  
  NOT-HG-20-055: Notice of Pre-Application Webinars for the Impact of Genomic Variation on Function (IGVF) Consortium FOAs (RFA-HG-20-043, RFA-HG-20-044, RFA-HG-20-045, RFA-HG-20-046, RFA-HG-20-047
•  

• Laboratory, Data Analysis, and Coordinating Center (LDACC) for the Developmental Genotype-Tissue Expression Project (U24 Clinical Trial Not Allowed)
  RFA-HG-20-039
  Application Due Date(s): November 13, 2020
  Expiration Date: November 14, 2020

• Advancing Genomic Medicine Research (Clinical Trial Optional) (R01)
  RFA-HG-20-036
  Due Dates: August 3, 2020; March 8, 2021; November 2, 2021; August 1, 2022; March 13, 2023
  Expiration Date: March 14, 2023

• Advancing Genomic Medicine Research (Clinical Trial Optional) (R21)
  RFA-HG-20-037
  Due Dates: August 3, 2020; March 8, 2021; November 2, 2021; August 1, 2022; March 13, 2023
  Expiration Date: March 14, 2023

• Genomic Community Resources (U24)
  PAR-20-100
  Application Due Date(s): First due date is May 25, 2020; Standard dates apply after that, by 5:00 PM local time of applicant organization.
  Expiration Date: January 26, 2023
   
• Novel Synthetic Nucleic Acid Technology Development (R01 Clinical Trial not allowed)
  RFA-HG-20-014
  Application Due Date(s): June 24, 2020; February 1, 2021; October 1, 2021; June 24, 2022
  Expiration Date: June 25, 2022
   
• Novel Synthetic Nucleic Acid Technology Development (R21) (Clinical Trial not allowed)
  RFA-HG-20-015
  Application Due Date(s): June 24, 2020; February 1, 2021; October 1, 2021; June 24, 2022
  Expiration Date: June 25, 2022
   
• Novel Synthetic Nucleic Acid Technology Development (R43/R44) (Clinical Trial Not Allowed)
  RFA-HG-20-016
  Application Due Date(s): June 24, 2020; February 1, 2021; October 1, 2021; June 24, 2022
  Expiration Date: June 25, 2022
   
• Notice of Special Interest: Genomic Data Repositories (PAR-20-089) and Knowledgebases (PAR-20-097)
  NOT-HG-20-017
   
• Notice of Special Interest: Development of Statistical, Population Genetics and Computational Methods Related to Polygenic Prediction of Health and Disease in Diverse Populations
  NOT-HG-20-010
   
• Notice of Change: Emphasizing an Opportunity for New Institutional Applicants in Response to PAR-19-204 Centers of Excellence in Genomic Science (RM1 Clinical Trial Optional)
  NOT-HG-20-013
   
• NHGRI Implementation of the NIH Genomic Data Sharing Policy
  NOT-HG-20-011
   
• Notice of New NIH-Designated Data Repository: NHGRI’s Genomic Data Science Analysis, Visualization, and Informatics Lab-space (AnVIL)
  NOT-HG-19-024
   
• Centers of Excellence in Genomic Science (RM1 Clinical Trial Optional)
  PAR-19-204
  Application Due Date(s): May 20, 2019; May 18, 2020; May 20, 2021
  Expiration Date: May 21, 2021
   
• Investigator-Initiated Genomic Medicine Research (R01 Clinical Trial Optional)
  PAR-18-735
  Application Due Date(s): June 20, 2018; October 19, 2018; June 20, 2019; October 21, 2019; June 19, 2020; October 20, 2020
  Expiration Date: January 23, 2021
   
• Investigator-Initiated Genomic Medicine Research (R21 Clinical Trial Optional)
  PAR-18-736
  Application Due Date(s): June 20, 2018; October 19, 2018; June 20, 2019; October 21, 2019; June 19, 2020; October 20, 2020
  Expiration Date: January 23, 2021
  
  Notice of Early Expiration of PAR-18-735 (Investigator-Initiated Genomic Medicine Research (R01 Clinical Trial Optional) and PAR-18-736 (Investigator-Initiated Genomic Medicine Research (R21 Clinical Trial Optional)
  NOT-HG-20-051
   
• Genomic Innovator Award (R35 Clinical Trial Optional) 
  RFA-HG-18-006 
  Application Due Dates: October 30, 2018; October 30, 2019; October 30, 2020
  Expiration Date: October 31, 2020
  
  Notice of Pre-Application Webinars for the NHGRI Genomic Innovator Award
  NOT-HG-20-053
   
• Novel Approaches for Relating Genetic Variation to Function and Disease (R21 Clinical Trial Not Allowed) 
  PAR-18-867
  Application Due Dates: February 16, June 16, October 16
  Expiration Date: July 17, 2021
   
• Novel Approaches for Relating Genetic Variation to Function and Disease (R01 Clinical Trial Not Allowed) 
  PAR-18-868
  Application Due Dates: February 5, June 5, October 5
  Expiration Date: July 6, 2021
   
• Investigator Initiated Research in Computational Genomics and Data Science (R21 Clinical Trial Not Allowed) 
  PAR-18-843 
  Application Due Date(s): November 16, 2018; July 16, 2019; November 16, 2019; July 16, 2020; November 16, 2020; July 16, 2021?
  Expiration Date: September 8, 2021
   
• Investigator Initiated Research in Computational Genomics and Data Science (R01 Clinical Trial Not Allowed)  
  PAR-18-844
  Application Due Date(s): November 16, 2018; July 16, 2019; November 16, 2019; July 16, 2020; November 16, 2020; July 16, 2021
  Expiration Date: September 8, 2021
   
• Novel Genomic Technology Development (R01 Clinical Trial Not Allowed) 
  PAR-18-777 
  Application Due Date(s): October 2, 2018; October 2, 2019; October 2, 2020
  Expiration Date: January 8, 2021

• Novel Genomic Technology Development (R43/R44 Clinical Trial Not Allowed) 
  PAR-18-779  
  Application Due Date(s): October 2, 2018; October 2, 2019; October 2, 2020
  Expiration Date: January 8, 2021

• Novel Genomic Technology Development (R21 Clinical Trial Not Allowed) 
  PAR-18-778
  Application Due Date(s): October 2, 2018; October 2, 2019; October 2, 2020
  Expiration Date: January 8, 2021

• Novel Nucleic Acid Sequencing Technology Development (R01 Clinical Trial Not Allowed)
  RFA-HG-18-001
  Application Due Date(s): June 27, 2018; June 27, 2019; June 26, 2020
  Expiration Date: September 11, 2020

• Novel Nucleic Acid Sequencing Technology Development (R21 Clinical Trial Not Allowed)
  RFA-HG-18-002 
  Application Due Date(s): June 27, 2018; June 27, 2019; June 26, 2020
  Expiration Date: September 11, 2020

• Novel Nucleic Acid Sequencing Technology Development (R43/R44 Clinical Trial Not Allowed)
  RFA-HG-18-003 
  Application Due Date(s): June 27, 2018; June 27, 2019; June 26, 2020
  Expiration Date: September 11, 2020

• Comparative Genomics Research Program (R01-Clinical Trial Not Allowed)
  PAR-17-482 
  Application Due Date(s): February 5, June 5, October 5
  Expiration Date: January 8, 2021
   
  • Notice of U.S. Department of Agriculture (USDA) Participation in PAR-17-482 "Comparative Genomics Research Program (R01) 
    NOT-HG-18-007 
     
  • Frequently Asked Questions: PAR-18-482 Comparative Genomics Research Program 
     
• Ethical, Legal, and Social Implications (ELSI) of Genomic Research Regular Research Program (R01) 
  PA-17-325 
  Application Receipt Date(s): Standard dates apply
  Expiration Date: September 8, 2020
   
• Ethical, Legal, and Social Implications (ELSI) of Genomic Research Small Research Grant Program (R03) 
  PA-17-324 
  Application Receipt Date(s): Standard dates apply
  Expiration Date: September 8, 2020
   
• Ethical, Legal, and Social Implications (ELSI) of Genomic Research Exploratory/Developmental Research Grant Program (R21) 
  PA-17-323 
  Application Receipt Date(s): Standard dates apply
  Expiration Date: September 8, 2020

• NIH Exploratory/Developmental Research Grant Program (Parent R21 Clinical Trial Required)
  PA-20-194
  Application Due Dates: February 16, June 16, October 16
  Expiration Date: May 8, 2023
   
• NIH Exploratory/Developmental Research Grant Program (Parent R21 Clinical Trial Not Allowed)
  PA-20-195
  Application Due Dates: February 16, June 16, October 16
  Expiration Date: May 8, 2023
   
• NIH Research Project Grant (Parent R01 Clinical Trial Not Allowed)
  PA-19-056
  Application Receipt Date(s): February 5, June 5, October 5
  Expiration Date: January 8, 2022
   
• Research Project Grant (Parent R01 Clinical Trial Required)
  PA-19-055
  Application Receipt Date(s): February 5, June 5, October 5
  Expiration Date: January 8, 2022
   
• SBIR/STTR Commercialization Readiness Pilot (CRP) Program Technical Assistance (SB1, R44) Clinical Trial Not Allowed
  PAR-19-334
   
• Notice of Special Interest: Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) Applications Directed at the Adoption of the Fast Healthcare Interoperability Resources (FHIR®) Standard
  NOT-OD-19-127
   
• Change of Grantee Organization (Type 7 Parent Clinical Trial Optional)
  PA-18-590 
  Application Receipt Date(s): A change of grantee organization request must be made before the anticipated start date at the new organization and preferably several months in advance.
  Expiration Date: January 26, 2021
   
• Successor-in-Interest (Type 6 Parent Clinical Trial Optional)
  PA-18-589 
  Application Receipt Date(s): A change of grantee organization request must be made before the anticipated start date at the new organization and preferably several months in advance.
  Expiration Date: January 26, 2021
   
• NIH Small Research Grant Program (Parent R03 Clinical Trial Not Allowed)
  PA-19-052

• NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed) 
  PA-18-648 
  Application Due Date(s): April 12, August 12, December 12
  Expiration Date: January 8, 2021

• Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Admin Supp)
  PA-18-591 
  Application Receipt Date(s): Multiple dates, see announcement.
  Expiration Date: January 26, 2021
  
  Administrative Supplements - NHGRI Guidance

• Academic Research Enhancement Award (Parent R15 Clinical Trial Not Allowed)
  PA-18-504 
  Application Due Date(s): February 25, June 25, October 25
  Expiration Date: January 8, 2021
• NIH Exploratory/Developmental Research Grant Program (Parent R21 Clinical Trial Required) 
  PA-18-344 
  Application Receipt Date(s): February 16, June 16, October 16
  Expiration Date: January 8, 2021
   
  • Companion Funding Opportunity:
    PA-18-489 - NIH Exploratory/Developmental Research Grant Program (Parent R21 Clinical Trial Not Allowed)
     
• Research on the Health of Transgender and Gender Nonconforming Populations (R21) 
  PA-17-477 
  Application Receipt Date(s): February 16, June 16, October 16
  Expiration Date: September 8, 2020
   
• Research on the Health of Transgender and Gender Nonconforming Populations (R01) 
  PA-17-478 
  Application Receipt Date(s): February 5, June 5, October 5
  Expiration Date: September 8, 2020
   

• Notice of Special Interest (NOSI) regarding the Availability of Urgent Competitive Revisions and Administrative Supplements for Research on Coronavirus Disease 2019 (COVID-19) in Individuals with Down Syndrome for the INCLUDE Project
  NOT-OD-20-129

• Notice of Common Funds Participation in PA-20-135 "Emergency Competitive Revision to Existing NIH Awards (Emergency Supplement - Clinical Trial Optional)"
  NOT-RM-20-016

• Lasker Clinical Research Scholars Program (Si2/R00 Clinical Trial Optional)
  PAR-20-167
  Application Due Date(s): August 28, 2020
  Expiration Date: August 29, 2020

• Notice of NHGRI’s Participation in PA-18-935 "Urgent Competitive Revision to Existing NIH Grants and Cooperative Agreements (Urgent Supplement - Clinical Trial Optional)"
  NOT-HG-20-034

• Notice of Special Interest (NOSI) regarding the Availability of Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus
  NOT-HG-20-030

• Notice of Special Interest (NOSI): Availability of Administrative Supplements to Advance Safe and Effective Therapeutics in Pregnant and Lactating Women and Children
  NOT-HD-20-003

• Emergency Competitive Revision to Existing NIH Awards (Emergency Supplement - Clinical Trial Optional)
  PA-20-135
  Application Due Date(s): See the Emergency Notice of Special Interest (NOSI) for any applicable Application Due Dates.
  Expiration Date: March 10, 2023

• Notice of Special Interest (NOSI): Administrative Supplements to Support Enhancement of Software Tools for Open Science
  NOT-OD-20-073

• Development of Highly Innovative Tools and Technology for Analysis of Single Cells (STTR) (R41/R42 Clinical Trial Not Allowed)
  PA-20-025
  Application Due Date(s): September 5, January 5, April 5
  Expiration Date: January 6, 2023

• Development of Highly Innovative Tools and Technology for Analysis of Single Cells (SBIR) (R43/R44 Clinical Trial Not Allowed)
  PA-20-047
  Application Due Date(s): September 5, January 5, April 5
  Expiration Date: January 6, 2023

• Notice of Special Interest: Administrative Supplements to Promote Research Continuity and Retention of NIH Mentored Career Development (K) Award Recipients and Scholars
  NOT-OD-20-054

• Notice of Special Interest (NOSI): Ruth L. Kirschstein National Research Service Award (NRSA) Fellowship Awards to Support Training in Research Related to Down Syndrome as Part of the INCLUDE Project
  NOT-OD-20-020

• Notice of Special Interest (NOSI): Mentored Career Development Awards to Foster the Careers of Investigators Pursuing Research Related to Down syndrome as Part of the INCLUDE Project
  NOT-OD-20-021

• Notice of Special Interest: Research on the Health of Women of Understudied, Underrepresented and Underreported (U3) Populations (Admin Supp Clinical Trial Optional)
  NOT-OD-20-048

• Notice of Special Interest: Administrative Supplements for Research on Sex/Gender Influences (Admin Supp Clinical Trial Optional)
  NOT-OD-20-049

• Notice of NHGRI Participation in PAR-19-372, Social Epigenomics Research Focused on Minority Health and Health Disparities (R01-Clinical Trial Not Allowed)
  NOT-HG-19-026

• Dissemination and Implementation Research in Health (R01 Clinical Trial Optional)
  PAR-19-274
  Application Receipt/Submission Date(s): February 5, June 5, October 5
  Expiration Date: May 8, 2022

• Dissemination and Implementation Research in Health (R21 Clinical Trial Optional)
  PAR-19-275
  Application Receipt/Submission Date(s): February 16, June 16, October 16
  Expiration Date: May 8, 2022

• Dissemination and Implementation Research in Health (R03 Clinical Trial Not Allowed)
  PAR-19-276
  Application Receipt/Submission Date(s): February 16, June 16, October 16
  Expiration Date: May 8, 2022

• International Bioethics Research Training Program (D43 Clinical Trial Optional)
  PAR-19-243
  Application Receipt/Submission Date(s): June 4, 2019; June 4, 2020, June 4, 2021
  Expiration Date: June 5, 2021

• International Research Ethics Education and Curriculum Development Award (R25 Clinical Trial Not Allowed)
  PAR-19-244
  Application Receipt/Submission Date(s): June 4, 2019, June 4, 2020, June 4, 2021
  Expiration Date: June 5, 2021

• NIH Highlights Support for Data Science Research through the Academic Research Enhancement Award (AREA) Program
  NOT-GM-19-021 
   
• Notice of Special Interest in Research on the Health of Sexual and Gender Minority (SGM) Populations
  NOT-MD-19-001 
   
• National Science Foundation - National Institutes of Health NSF-NIH Interagency Initiative: Smart and Connected Health
  NOT-OD-18-149 

• Academic Academic Research Enhancement Award for Undergraduate-Focused Institutions (R15 - Clinical Trial Not Allowed) 
  PAR-18-714 
  Application Due Date: February 25, June 25, October 25
  Expiration Date: May 8, 2021

• Research on the Health of Transgender and Gender Nonconforming Populations (R21 Clinical Trial Optional) 
  PA-18-728 
  Application Due Date(s): February 16, June 16, October 16
  Expiration Date: January 8, 2021 
   
• Research on the Health of Transgender and Gender Nonconforming Populations (R01 Clinical Trial Optional) 
  PA-18-729 
  Application Due Date(s): February 5, June 5, October 5
  Expiration Date: January 8, 2021 
   
• National Science Foundation - National Institutes of Health NSF-NIH Interagency Initiative: Smart and Connected Health 
  NOT-OD-18-149 
   
• Announcing the High-Priority, Short-Term Project Award (R56) 
  • Notice of NHGRI's Participation in NOT-OD-04-047 "High Priority, Short-Term Project Award (R56)" 
    NOT-HG-17-004 [grants.nih.gov]